Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver disease
liver disease
FDA approves expanded use of Mirum's liver disease drug
Reuters
Wed, 03/13/24 - 10:40 pm
Mirum Pharmaceuticals
FDA
liver disease
PFIC
Gilead pays $4.3B for CymaBay, the biotech that never gave up on liver disease med
Fierce Biotech
Mon, 02/12/24 - 11:53 am
Gilead Sciences
CymaBay Therapeutics
M&A
liver disease
seladelpar
primary biliary cholangitis
Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch
Stat
Thu, 12/21/23 - 09:52 am
obesity
climate change
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
liver disease
Ipsen, eyeing approval, reveals mixed liver disease data on challenger to Intercept and CymaBay
Fierce Biotech
Tue, 11/14/23 - 09:20 am
Ipsen
Genfit
elafibranor
liver disease
Intercept Pharma
CymaBay Therapeutics
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Genethon’s Gene Therapy for Rare Liver Disease Shows Promising Early-Stage Results
BioSpace
Fri, 08/18/23 - 11:37 am
Genethon
gene therapy
Crigler-Najjar Syndrome
liver disease
clinical trials
Ipsen and Genfit to file for EMA and FDA approval for elafibranor
Clinical Trials Arena
Fri, 06/30/23 - 10:12 am
Ipsen
Genfit
EMA
FDA
elafibranor
liver disease
primary biliary cholangitis
After Albireo buyout, Ipsen's Bylvay picks up new FDA-approved use
Fierce Pharma
Wed, 06/14/23 - 10:22 am
Ipsen
Bylvay
Albireo Pharma
M&A
FDA
liver disease
Mallinckrodt secures FDA approval — but not without warning
Endpoints
Thu, 09/15/22 - 11:18 pm
Mallinckrodt
FDA
terlipressin
Terlivaz
liver disease
hepatorenal syndrome
Vertex, Verve team up to develop a gene editing drug for liver disease
Biopharma Dive
Wed, 07/20/22 - 11:24 pm
Vertex Pharma
Verve Therapeutics
liver disease
Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver Conference
BioSpace
Tue, 06/28/22 - 10:49 am
EASL
liver disease
Ascletis
Takeda
Arrowhead Pharmaceuticals
Laekna Therapeutics Raises $61 Million in Series D financing
BioSpace
Wed, 05/18/22 - 10:28 am
Laekna Therapeutics
funding
liver disease
cancer
Intercept sells international rights to liver drug in $400M deal
BioPharma Dive
Thu, 05/5/22 - 11:23 pm
Intercept Pharma
Advanz Pharma
Ocaliva
liver disease
89bio gains a little more confidence in NASH treatment with new hormone data
Fierce Biotech
Sun, 03/27/22 - 03:52 pm
89Bio
NASH
liver disease
pegozafermin
Digital health firm ChronWell raises $6m for liver disease toolkit
Pharmaforum
Fri, 12/10/21 - 10:59 am
ChronWell
liver disease
digital health
digital therapeutics
patient managment
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Wed, 11/10/21 - 10:17 am
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Genevant, Takeda Enter Collab to Find a Cure for Rare Liver Diseases
BioSpace
Mon, 08/23/21 - 11:13 am
Genevant Sciences
Takeda
liver disease
drug development
Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit
Pharmaforum
Wed, 01/6/21 - 10:42 am
Novo Nordisk
Dicerna
gene silencing
liver disease
Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B
Fierce Biotech
Wed, 10/14/20 - 10:49 am
Dyno
Roche
Spark Therapeutics
gene therapy
liver disease
CNS
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug
Xconomy
Wed, 09/16/20 - 07:28 pm
Arrowhead Pharmaceuticals
clinical trials
liver disease
RNAi
ARO-AAT
Pages
1
2
3
next ›
last »